Ironwood Pharmaceuticals (IRWD) PT Lowered to $17 at BTIG
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $4.36 +3.07%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
BTIG analyst Timothy Chiang lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $17.00 (from $21.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades Franklin BSP Realty Trust (FBRT) to Neutral
- Sumitomo Metal Mining Co Ltd (5713:JP) PT Raised to JPY9,900 at Nomura/Instinet
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
